Description
Cagrilintide is a long-acting analogue of the naturally occurring hormone amylin. It is being investigated for its activity at amylin and calcitonin receptors and for its effects on biological pathways involved in appetite, satiety, and energy intake.
Clinical research has evaluated cagrilintide both independently and in combination with GLP-1–based compounds, particularly in studies involving obesity and body-weight management. Unlike GLP-1 receptor agonists, cagrilintide primarily targets amylin-related signaling, making it a distinct compound for metabolic research.
Each vial contains 10mg of Cagrilintide in a lyophilized formulation intended exclusively for laboratory and scientific research.
Product Highlights
- 10mg Cagrilintide per vial
- Long-acting amylin analogue
- Investigated in appetite and satiety research
- Studied in metabolic and body-weight research
- Distinct mechanism from GLP-1 receptor agonists
- Lyophilized research formulation
Research Use Only
For laboratory and scientific research purposes only. Not for human consumption, diagnostic use, or therapeutic use.
Reviews
There are no reviews yet.